Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, Murray LJ.

J Natl Cancer Inst. 2011 Jul 6;103(13):1049-57. doi: 10.1093/jnci/djr203. Epub 2011 Jun 16. Erratum in: J Natl Cancer Inst. 2013 Apr 17;105(8):581.

2.

The diagnosis and management of Barrett's esophagus.

DeMeester SR, DeMeester TR.

Adv Surg. 1999;33:29-68. Review.

PMID:
10572561
3.
4.

[Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].

Zaninotto G, Costantini M, Molena D, Rizzetto C, Ekser B, Ancona E.

Minerva Chir. 2002 Dec;57(6):819-36. Review. Italian.

PMID:
12592224
5.

Barrett's esophagus and risk of esophageal adenocarcinoma.

Cossentino MJ, Wong RK.

Semin Gastrointest Dis. 2003 Jul;14(3):128-35. Review.

PMID:
14653412
6.

Diagnosis and recognition of early esophageal neoplasia.

Herszényi L, Pregun I, Tulassay Z.

Dig Dis. 2009;27(1):24-30. doi: 10.1159/000210100. Epub 2009 May 8. Review.

PMID:
19439957
7.

Barrett's esophagus: histopathologic definitions and diagnostic criteria.

Mueller J, Werner M, Stolte M.

World J Surg. 2004 Feb;28(2):148-54. Epub 2004 Jan 20. Review.

PMID:
14727064
8.

Endoscopic follow-up and management of Barrett's esophagus in relation to its preneoplastic potential.

Navarro-Dourdil M, Charro-Calvillo M, Uribarrena-Amézaga R, Sebastián-Domingo JJ.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1241-5. Review.

PMID:
25436290
9.

Barrett's esophagus, dysplasia, and adenocarcinoma.

Haggitt RC.

Hum Pathol. 1994 Oct;25(10):982-93. Review.

PMID:
7927321
10.

Carditis, intestinal metaplasia and adenocarcinoma of oesophagogastric junction.

Conio M, Filiberti R, Blanchi S, Giacosa A.

Eur J Cancer Prev. 2001 Dec;10(6):483-7. Review.

PMID:
11916346
11.

The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.

Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L.

Am J Epidemiol. 2008 Aug 1;168(3):237-49. doi: 10.1093/aje/kwn121. Epub 2008 Jun 12. Review.

12.

[Surveillance of patients with Barrett's esophagus].

Endlicher E, Knüchel R, Messmann H.

Z Gastroenterol. 2001 Aug;39(8):593-600. Review. German.

PMID:
11558064
13.

Surgical management of Barrett's esophagus.

Clark GW, DeMeester TR.

Ann Chir Gynaecol. 1995;84(2):139-44. Review.

PMID:
7574371
14.

Screening and surveillance for complications related to gastroesophageal reflux disease.

Spechler SJ.

Am J Med. 2001 Dec 3;111 Suppl 8A:130S-136S. Review.

PMID:
11749938
15.

[Barrett esophagus--an increasing problem].

Berstad A, Hatlebakk JG, Giercksky KE.

Tidsskr Nor Laegeforen. 1998 Oct 30;118(26):4100-3. Review. Norwegian.

PMID:
9844516
16.

Barrett's esophagus and esophageal adenocarcinoma.

Reid BJ.

Gastroenterol Clin North Am. 1991 Dec;20(4):817-34. Review.

PMID:
1787015
17.

Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.

Whitson MJ, Falk GW.

Gastroenterol Clin North Am. 2015 Jun;44(2):299-315. doi: 10.1016/j.gtc.2015.02.005. Epub 2015 Mar 31. Review.

18.

Barrett's oesophagus: frequency and prediction of dysplasia and cancer.

Falk GW.

Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):125-38. doi: 10.1016/j.bpg.2015.01.001. Epub 2015 Jan 20. Review.

19.

Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.

Vial M, Grande L, Pera M.

Recent Results Cancer Res. 2010;182:1-17. doi: 10.1007/978-3-540-70579-6_1. Review.

PMID:
20676867
20.

Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma.

Carr JS, Zafar SF, Saba N, Khuri FR, El-Rayes BF.

J Gastrointest Cancer. 2013 Jun;44(2):143-51. doi: 10.1007/s12029-013-9480-z. Review.

PMID:
23435833
Items per page

Supplemental Content

Write to the Help Desk